Logo image of HBT

HBT FINANCIAL INC/DE (HBT) Stock Fundamental Analysis

NASDAQ:HBT - Nasdaq - US4041111067 - Common Stock - Currency: USD

25.68  +0.22 (+0.86%)

After market: 25.68 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to HBT. HBT was compared to 393 industry peers in the Banks industry. HBT has a medium profitability rating, but doesn't score so well on its financial health evaluation. HBT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HBT had positive earnings in the past year.
In the past year HBT had a positive cash flow from operations.
HBT had positive earnings in each of the past 5 years.
In the past 5 years HBT always reported a positive cash flow from operatings.
HBT Yearly Net Income VS EBIT VS OCF VS FCFHBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

The Return On Assets of HBT (1.48%) is better than 88.89% of its industry peers.
With an excellent Return On Equity value of 13.37%, HBT belongs to the best of the industry, outperforming 88.13% of the companies in the same industry.
Industry RankSector Rank
ROA 1.48%
ROE 13.37%
ROIC N/A
ROA(3y)1.35%
ROA(5y)1.27%
ROE(3y)13.91%
ROE(5y)13.1%
ROIC(3y)N/A
ROIC(5y)N/A
HBT Yearly ROA, ROE, ROICHBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of HBT (32.82%) is better than 88.13% of its industry peers.
In the last couple of years the Profit Margin of HBT has declined.
The Operating Margin and Gross Margin are not available for HBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 32.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-3.13%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5YN/A
HBT Yearly Profit, Operating, Gross MarginsHBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

HBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
HBT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HBT has more shares outstanding
HBT has a better debt/assets ratio than last year.
HBT Yearly Shares OutstandingHBT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HBT Yearly Total Debt VS Total AssetsHBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

HBT has a debt to FCF ratio of 1.09. This is a very positive value and a sign of high solvency as it would only need 1.09 years to pay back of all of its debts.
HBT has a better Debt to FCF ratio (1.09) than 72.22% of its industry peers.
HBT has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.17, HBT perfoms like the industry average, outperforming 50.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.09
Altman-Z N/A
ROIC/WACCN/A
WACC12.74%
HBT Yearly LT Debt VS Equity VS FCFHBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HBT Yearly Current Assets VS Current LiabilitesHBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

HBT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.42%.
The Earnings Per Share has been decreasing by -7.43% on average over the past years.
HBT shows a decrease in Revenue. In the last year, the revenue decreased by -1.19%.
Measured over the past years, HBT shows a small growth in Revenue. The Revenue has been growing by 6.49% on average per year.
EPS 1Y (TTM)3.42%
EPS 3Y5.17%
EPS 5Y-7.43%
EPS Q2Q%7.02%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y12.01%
Revenue growth 5Y6.49%
Sales Q2Q%3.81%

3.2 Future

Based on estimates for the next years, HBT will show a small growth in Earnings Per Share. The EPS will grow by 1.55% on average per year.
The Revenue is expected to grow by 3.84% on average over the next years.
EPS Next Y3.89%
EPS Next 2Y1.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.94%
Revenue Next 2Y3.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HBT Yearly Revenue VS EstimatesHBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
HBT Yearly EPS VS EstimatesHBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

HBT is valuated reasonably with a Price/Earnings ratio of 10.61.
HBT's Price/Earnings ratio is a bit cheaper when compared to the industry. HBT is cheaper than 73.23% of the companies in the same industry.
When comparing the Price/Earnings ratio of HBT to the average of the S&P500 Index (28.05), we can say HBT is valued rather cheaply.
The Price/Forward Earnings ratio is 10.60, which indicates a very decent valuation of HBT.
The rest of the industry has a similar Price/Forward Earnings ratio as HBT.
HBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.67.
Industry RankSector Rank
PE 10.61
Fwd PE 10.6
HBT Price Earnings VS Forward Price EarningsHBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HBT is valued a bit cheaper than the industry average as 70.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.26
EV/EBITDA N/A
HBT Per share dataHBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.73
PEG (5Y)N/A
EPS Next 2Y1.55%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

HBT has a Yearly Dividend Yield of 3.18%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.38, HBT has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.30, HBT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.18%

5.2 History

HBT has been paying a dividend for over 5 years, so it has already some track record.
HBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years4
HBT Yearly Dividends per shareHBT Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

32.81% of the earnings are spent on dividend by HBT. This is a low number and sustainable payout ratio.
DP32.81%
EPS Next 2Y1.55%
EPS Next 3YN/A
HBT Yearly Income VS Free CF VS DividendHBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HBT Dividend Payout.HBT Dividend Payout, showing the Payout Ratio.HBT Dividend Payout.PayoutRetained Earnings

HBT FINANCIAL INC/DE

NASDAQ:HBT (7/25/2025, 8:00:01 PM)

After market: 25.68 0 (0%)

25.68

+0.22 (+0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)10-20 2025-10-20/bmo
Inst Owners24.8%
Inst Owner Change-0.7%
Ins Owners5.2%
Ins Owner Change3.23%
Market Cap808.92M
Analysts75.56
Price Target26.32 (2.49%)
Short Float %0.85%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 3.18%
Yearly Dividend0.76
Dividend Growth(5Y)N/A
DP32.81%
Div Incr Years3
Div Non Decr Years4
Ex-Date08-05 2025-08-05 (0.21)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.53%
Min EPS beat(2)5.48%
Max EPS beat(2)9.58%
EPS beat(4)3
Avg EPS beat(4)3.71%
Min EPS beat(4)-1.77%
Max EPS beat(4)9.58%
EPS beat(8)5
Avg EPS beat(8)1.43%
EPS beat(12)9
Avg EPS beat(12)4.08%
EPS beat(16)13
Avg EPS beat(16)6.31%
Revenue beat(2)2
Avg Revenue beat(2)0.94%
Min Revenue beat(2)0.21%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-2.23%
Max Revenue beat(4)1.66%
Revenue beat(8)2
Avg Revenue beat(8)-3.16%
Revenue beat(12)4
Avg Revenue beat(12)-2.37%
Revenue beat(16)6
Avg Revenue beat(16)-1.85%
PT rev (1m)0%
PT rev (3m)4.03%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)3.96%
EPS NY rev (1m)0%
EPS NY rev (3m)4.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE 10.61
Fwd PE 10.6
P/S 3.52
P/FCF 9.26
P/OCF 8.72
P/B 1.43
P/tB 1.72
EV/EBITDA N/A
EPS(TTM)2.42
EY9.42%
EPS(NY)2.42
Fwd EY9.44%
FCF(TTM)2.77
FCFY10.79%
OCF(TTM)2.95
OCFY11.47%
SpS7.31
BVpS17.94
TBVpS14.91
PEG (NY)2.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 13.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 32.82%
GM N/A
FCFM 37.95%
ROA(3y)1.35%
ROA(5y)1.27%
ROE(3y)13.91%
ROE(5y)13.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-3.13%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.09
Debt/EBITDA N/A
Cap/Depr 94.77%
Cap/Sales 2.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 115.62%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score9
WACC12.74%
ROIC/WACCN/A
Cap/Depr(3y)58.77%
Cap/Depr(5y)49.18%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.26%
Profit Quality(3y)112.99%
Profit Quality(5y)98.71%
High Growth Momentum
Growth
EPS 1Y (TTM)3.42%
EPS 3Y5.17%
EPS 5Y-7.43%
EPS Q2Q%7.02%
EPS Next Y3.89%
EPS Next 2Y1.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y12.01%
Revenue growth 5Y6.49%
Sales Q2Q%3.81%
Revenue Next Year4.94%
Revenue Next 2Y3.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.2%
FCF growth 3Y25.94%
FCF growth 5Y-0.73%
OCF growth 1Y27.42%
OCF growth 3Y27.6%
OCF growth 5Y0.06%